Skip to content

13F-HR filed by Soleus Capital Management, L.P.

Soleus Capital Management, L.P. filed this 13F-HR for the quarter ended 2020-06-30, filed 2020-08-14, with 61 holding rows worth $175,431,000.

Accession
0001802630-20-000007
Filed
2020-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2020

A holdings report, 61 entries on the cover page, a total value of $175,431,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $175,406,000 with VALUE read as thousands by filing date, 13F file number 028-20043. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ZYMEWORKS INC98985W102COM420,836$15,179,000thousands by filing date
ESSA PHARMA INC29668H708COM NEW2,082,185$12,909,000thousands by filing date
ZYMEWORKS INC98985W102COM327,900$11,827,000thousands by filing dateput
IVERIC BIO INC46583P102COM1,626,701$8,296,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR136,214$7,204,000thousands by filing date
PROTHENA CORP PLC SHSG72800108Stock674,603$7,056,000thousands by filing date
QUIDEL CORP74838J101COM30,900$6,913,000thousands by filing date
EIGER BIOPHARMACEUTICALS INC28249U105COM620,266$5,954,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM50,789$5,700,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM34,500$5,531,000thousands by filing date
IRADIMED CORP46266A109COMMON STOCK212,436$4,930,000thousands by filing date
Adverum Biotechnologies, Inc.00773U108Common Stock218,723$4,566,000thousands by filing date
ZYNEX INC98986M103COM176,541$4,390,000thousands by filing date
IMMUNOMEDICS INC452907108COM119,000$4,217,000thousands by filing date
DEXCOM INC COM252131107Stock9,550$3,871,000thousands by filing date
AEGLEA BIOTHERAPEUTICS INC00773J103COM369,852$3,421,000thousands by filing date
Eli Lilly and Company532457108COM20,800$3,414,000thousands by filing date
NOVOCURE LTDG6674U108ORD SHS56,397$3,344,000thousands by filing date
VERICEL CORP92346J108COM238,532$3,296,000thousands by filing date
INARI MED INC45332Y109COM65,817$3,188,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock250,897$3,146,000thousands by filing date
AbbVie,Inc.00287Y109COM28,900$2,837,000thousands by filing date
Misonix Inc604871103COM196,301$2,663,000thousands by filing date
ITAMAR MED LTD SPONSORED ADS465437101ADR140,524$2,613,000thousands by filing date
ORASURE TECHNOLOGIES INC68554V108COM223,200$2,595,000thousands by filing date
HUMANA INC COM444859102Stock6,600$2,559,000thousands by filing date
NEVRO CORP64157F103COM18,800$2,246,000thousands by filing date
IONIS PHARMACEUTICALS INC COM462222100Stock36,400$2,146,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM127,300$1,919,000thousands by filing date
Surmodics Inc868873100Common Stock43,978$1,901,000thousands by filing date
AXONICS INC05465P101COM48,800$1,713,000thousands by filing date
HORIZON THERAPEUTICS PLCG46188101SHS29,600$1,645,000thousands by filing date
Rafael Holdings Inc Class B75062E106COM104,737$1,505,000thousands by filing date
CRISPR THERAPEUTICS AG NAMEN AKTH17182108Stock17,200$1,264,000thousands by filing date
STAAR SURGICAL CO COM PAR $0.01852312305Stock20,428$1,257,000thousands by filing date
SILK ROAD MEDICAL INC82710M100COMMON STOCK27,711$1,160,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM33,000$1,132,000thousands by filing date
KADMON HLDGS INC48283N106COM200,841$1,028,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM14,000$1,023,000thousands by filing date
CONSTELLATION PHARMACEUTICALS INC.210373106Common Stock33,400$1,003,000thousands by filing date
GOSSAMER BIO INC38341PAA0NOTE 5.000% 6/01,000,000$1,001,000thousands by filing dateprincipal
VAPOTHERM INC922107107COM21,700$889,000thousands by filing date
DYNAVAX TECHNOLOGIES CORP268158201COM NEW100,000$887,000thousands by filing date
PROVENTION BIO INC74374N102COM59,900$845,000thousands by filing date
INSULET CORP COM45784P101Stock4,000$777,000thousands by filing date
MASIMO CORP COM574795100Stock3,400$775,000thousands by filing date
AXOGEN INC05463X106COM80,350$742,000thousands by filing date
REVANCE THERAPEUTICS INC761330109COM28,469$695,000thousands by filing date
LYRA THERAPEUTICS INC55234L105COM60,670$687,000thousands by filing date
PACIRA BIOSCIENCES INC COM695127100Stock12,200$640,000thousands by filing date
ANTARES PHARMA INC036642106COM229,046$629,000thousands by filing date
BIOGEN INC COM09062X103Stock2,300$615,000thousands by filing date
ENANTA PHARMACEUTICALS INC29251M106COM11,500$577,000thousands by filing date
CASTLE BIOSCIENCES INC14843C105COMMON STOCK15,000$565,000thousands by filing date
HARPOON THERAPEUTICS INC41358P106COM30,886$512,000thousands by filing date
INSPIRE MED SYS INC COM457730109Stock5,608$488,000thousands by filing date
RAPT THERAPEUTICS INC75382E109COM15,100$438,000thousands by filing date
LARIMAR THERAPEUTICS INC517125100COM31,170$400,000thousands by filing date
RELMADA THERAPEUTICS INC75955J402COMMON STOCK6,900$308,000thousands by filing date
ARVINAS INC04335A105COM6,000$201,000thousands by filing date
INSMED INC457669AA7NOTE 1.750% 1/1180,000$174,000thousands by filing dateprincipal

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001802630-20-000007this filing2020-08-14acceptance time not in the bulk data set